Back to Journals » Neuropsychiatric Disease and Treatment

ISSN: 1178-2021


Journal Articles:

An Effectiveness Trial of an Exercise Physiologist Service to Improve Quality of Life in Adults with Severe Mental Illness: Protocol for the MOVEMENT Study

Chapman JJ, Siskind D, Yung AR, Lee YY, Arnautovska U, Scott JG, Burke K, Malacova E, Korman N, Wyder M, Doohan MA, Keating SE, Parker S, Walker ME, Hu D, O’Brien J, Lau G, Pratt GF, Rosenbaum S, Curtis J, Chatterton ML, Simmons L, Wheeler AJ

Neuropsychiatric Disease and Treatment 2025, 21:1399-1408

Published Date: 11 July 2025

A Novel Digital Intervention to Facilitate Diabetes Self-Management Among People with Schizophrenia and Related Disorders: Development and Acceptability Testing of SMART

Arnautovska U, Ritchie G, Soole R, Menon A, Korman N, Milton A, Varnfield M, Kelly JT, Jansen PM, Baker A, Ireland D, Russell AW, Chapman J, Mulligan K, Hirani SP, Vitangcol KJ, McKeon G, Siskind D

Neuropsychiatric Disease and Treatment 2025, 21:1289-1305

Published Date: 26 June 2025

An Evaluation a PrEP-Focused HIV Prevention Intervention Tailored for Individuals with Opioid Use Disorder and Cognitive Dysfunction

Mistler CB, Huedo-Medina TB, Shrestha R, Gunstad J, Zelenev A, Copenhaver MM

Neuropsychiatric Disease and Treatment 2025, 21:1235-1248

Published Date: 24 June 2025

Characteristics of Parthenogenetic Stem Cells and Their Potential Treatment Strategy for Central Nervous System Diseases

Cai H, Huang J, Wang W, Lin W, Ahmed W, Lu D, Quan J, Chen L

Neuropsychiatric Disease and Treatment 2025, 21:213-227

Published Date: 3 February 2025

Multimodal Magnetic Resonance Findings in Parkinson’s Disease With “Antecedent Essential Tremor”: A Case Series of a Large Kindred

Kong Y, Yao L, Xiao X, Chen A, Wang K, Yan H, Sun R, Liu R, Kong Q

Neuropsychiatric Disease and Treatment 2025, 21:79-92

Published Date: 22 January 2025

Autism Prevalence Information And Diagnosis Processes In Cyprus, Greece And Malta

Petinou K, Vogindroukas I, Christopoulou M

Neuropsychiatric Disease and Treatment 2024, 20:2499-2505

Published Date: 12 December 2024

Building Bridges! Children with Autism Spectrum Disorder and Their Transition from Kindergarten to School – A Scoping Review

Chahboun S, Lefstad KT, Pettersen M, Åmot I, Thwala S

Neuropsychiatric Disease and Treatment 2024, 20:1823-1835

Published Date: 27 September 2024

Circulating Cell-Free Mitochondrial DNA in Plasma of Individuals with Schizophrenia and Cognitive Deficit in Mexican Population

Garcia-de la Cruz DD, Juarez-Rojop IE, Tovilla-Zarate CA, Nicolini H, Genis-Mendoza AD

Neuropsychiatric Disease and Treatment 2024, 20:1757-1765

Published Date: 21 September 2024

The Face of Autism in Israel

Ferman S, Segal O

Neuropsychiatric Disease and Treatment 2024, 20:1677-1692

Published Date: 7 September 2024

Risk Factors for Post-Stroke Seizures in a Tertiary Care Center: A Case–Control Study

Mohamed AA, Tan JK, Tan MM, Khoo CS, Wan Yahya WNN, Abd Rahman MSH, Sutan R, Tan HJ

Neuropsychiatric Disease and Treatment 2024, 20:1615-1628

Published Date: 26 August 2024

Autism in Taiwan and Thailand: Influences of Culture

Westby C, Chen KM, Cheng L, Jithavech P, Maroonroge S

Neuropsychiatric Disease and Treatment 2024, 20:1523-1538

Published Date: 2 August 2024

Cognition in Euthymic Patients with Bipolar Disorder: Do Not Forget to Account for Anxiety!

Yoldi-Negrete M, Fresán A, Jiménez-Rodríguez LI, Tirado-Durán EG

Neuropsychiatric Disease and Treatment 2024, 20:1181-1189

Published Date: 4 June 2024

Ensemble Learning for Higher Diagnostic Precision in Schizophrenia Using Peripheral Blood Gene Expression Profile

Wagh VV, Kottat T, Agrawal S, Purohit S, Pachpor TA, Narlikar L, Paralikar V, Khare SP

Neuropsychiatric Disease and Treatment 2024, 20:923-936

Published Date: 3 May 2024

Neuropsychiatric Symptoms Predict Faster Cognitive Decline in Dementia Collaborative Care Than Antipsychotic Use

Chen YJ, Chang MC, Jhang KM, Wang WF, Liao YC

Neuropsychiatric Disease and Treatment 2024, 20:689-696

Published Date: 26 March 2024

Endovascular Thrombectomy for Acute Ischemic Stroke in Indonesia: Challenging and Strategic Planning

Rilianto B, Kurniawan RG, Rajab NM, Prasetyo BT

Neuropsychiatric Disease and Treatment 2024, 20:621-630

Published Date: 21 March 2024

Validity and Reliability Study of the Turkish Version of the Orbach Mikulincer Mental Pain Scale-8 in a Clinical Population

Demirkol ME, Tamam L, Namlı Z, Yeşiloğlu C, Yılmaz H

Neuropsychiatric Disease and Treatment 2024, 20:429-438

Published Date: 1 March 2024

Hormonal Changes in Women with Epilepsy

Li Q, Zhang Z, Fang J

Neuropsychiatric Disease and Treatment 2024, 20:373-388

Published Date: 26 February 2024

What Do Farmers Need for Suicide Prevention: Considerations for a Hard-to-Reach Population

Scheyett A, Marburger IL, Scarrow A, Hollifield SM, Dunn JW

Neuropsychiatric Disease and Treatment 2024, 20:341-352

Published Date: 22 February 2024

A Thematic Analysis Investigating the Inaugural Psychosis REACH Family Ambassador Peer Training Program

Vaswani-Bye A, McCain C, Blank JM, Tennison ME, Kopelovich SL

Neuropsychiatric Disease and Treatment 2024, 20:233-245

Published Date: 8 February 2024

Excess Mortality in Individuals with Autism Spectrum Disorder: A Population-Based Cohort Study

Huang YH, Wu SI, Lee MJ, Chen YL, Yang YH, Kuo TY, Hung TH, Dewey ME, Stewart R, Chen VCH

Neuropsychiatric Disease and Treatment 2024, 20:247-255

Published Date: 8 February 2024

NR3C1 and NR3C2 Genes Increase the Risk of Suicide Attempt in Psychiatric Disorder Patients with History of Childhood Trauma

Sanabrais-Jiménez MA, Esquivel-López AA, Sotelo-Ramírez CE, Aguilar-García A, Ordoñez-Martínez B, Jiménez-Pavón J, Madrigal-Lara MV, Díaz-Vivanco AJ, Camarena B

Neuropsychiatric Disease and Treatment 2023, 19:2561-2571

Published Date: 24 November 2023

Genetic Susceptibility to Tardive Dyskinesia and Cognitive Impairments in Chinese Han Schizophrenia: Role of Oxidative Stress-Related and Adenosine Receptor Genes

Jiang Q, Zhang X, Lu X, Li Y, Lu C, Chi J, Ma Y, Shi X, Wang L, Li S

Neuropsychiatric Disease and Treatment 2023, 19:2499-2509

Published Date: 20 November 2023

Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study

Chiappini S, Di Carlo F, Mosca A, d'Andrea G, Di Paolo M, Lorenzini C, Lupica MG, Sampogna G, Pettorruso M, Fiorillo A, Martinotti G

Neuropsychiatric Disease and Treatment 2023, 19:1887-1897

Published Date: 30 August 2023

Peripheral Complement Factor-Based Biomarkers for Patients with First-Episode Schizophrenia

Cao Y, Xu Y, Xia Q, Shan F, Liang J

Neuropsychiatric Disease and Treatment 2023, 19:1455-1462

Published Date: 23 June 2023

Use of Selective Alternative Therapies for Treatment of OCD

Khan I, Jaura TA, Tukruna A, Arif A, Tebha SS, Nasir S, Mukherjee D, Masroor N, Yosufi A

Neuropsychiatric Disease and Treatment 2023, 19:721-732

Published Date: 5 April 2023

Impact of Childhood Adversity, as Early Life Distress, on Cytokine Alterations in Schizophrenia

Miljevic C, Munjiza-Jovanovic A, Jovanovic T

Neuropsychiatric Disease and Treatment 2023, 19:579-586

Published Date: 11 March 2023

Serum NOX1 and Raftlin as New Potential Biomarkers of Interest in Schizophrenia: A Preliminary Study

Hurşitoğlu O, Kurutas EB, Strawbridge R, Uygur OF, Yildiz E, Reilly TJ

Neuropsychiatric Disease and Treatment 2022, 18:2519-2527

Published Date: 2 November 2022

Focus on Issues and Solutions in Autism Spectrum Disorders (ASD)

Petinou K, Hus Y, Segal O

Neuropsychiatric Disease and Treatment 2022, 18:2273-2277

Published Date: 17 October 2022

Rehabilitation Services for Young Adults with ASD

Kristofik A, Johnson KL

Neuropsychiatric Disease and Treatment 2022, 18:2361-2366

Published Date: 17 October 2022

Recent Advances of Telepractice for Autism Spectrum Disorders in Speech and Language Pathology

Christopoulou M, Drosos K, Petinou K

Neuropsychiatric Disease and Treatment 2022, 18:2379-2389

Published Date: 14 October 2022

Language and Speech Characteristics in Autism

Vogindroukas I, Stankova M, Chelas EN, Proedrou A

Neuropsychiatric Disease and Treatment 2022, 18:2367-2377

Published Date: 14 October 2022

Cariprazine on Psychosis: Beyond Schizophrenia – A Case Series

Bajouco M, Mota D

Neuropsychiatric Disease and Treatment 2022, 18:1351-1362

Published Date: 5 July 2022

Cariprazine in Three Special Different Areas: A Real-World Experience

Gesi C, Paletta S, Palazzo M C, Dell'Osso B, Mencacci C, Cerveri G

Neuropsychiatric Disease and Treatment 2021, 17:3581-3588

Published Date: 7 December 2021

Cariprazine in Three Acute Patients with Schizophrenia: A Real-World Experience

Montes JM, Montes P, Hernández-Huerta D

Neuropsychiatric Disease and Treatment 2021, 17:291-296

Published Date: 3 February 2021

Caregiver perspective on pediatric attention-deficit/hyperactivity disorder: medication satisfaction and symptom control

Fridman M, Banaschewski T, Sikirica V, Quintero J, Erder MH, Chen KS

Neuropsychiatric Disease and Treatment 2017, 13:443-455

Published Date: 13 February 2017

Improvement of the noradrenergic symptom cluster following treatment with milnacipran

Kasper S, Meshkat D, Kutzelnigg A

Neuropsychiatric Disease and Treatment 2011, 7:21-27

Published Date: 31 May 2011

Noradrenergic symptom cluster in depression

Montgomery S, Briley M

Neuropsychiatric Disease and Treatment 2011, 7:1-2

Published Date: 31 May 2011

The increasing burden of depression

Lépine J-P, Briley M

Neuropsychiatric Disease and Treatment 2011, 7:3-7

Published Date: 31 May 2011

The importance of norepinephrine in depression

Moret C, Briley M

Neuropsychiatric Disease and Treatment 2011, 7:9-13

Published Date: 31 May 2011

Milnacipran: a unique antidepressant?

Siegfried Kasper, Gerald Pail

Neuropsychiatric Disease and Treatment 2010, 6:23-31

Published Date: 25 August 2010

Antidepressant therapy with milnacipran and venlafaxine

Lucilla Mansuy

Neuropsychiatric Disease and Treatment 2010, 6:17-22

Published Date: 25 August 2010

Milnacipran: recent findings in depression

Guest editors: Stuart Montgomery (London, UK) and Mike Briley (Castres, France)

Neuropsychiatric Disease and Treatment 2010, 6:0-0

Published Date: 24 August 2010

Editorial Foreword - Milnacipran: recent findings in depression

Stuart Montgomery, Mike Briley

Neuropsychiatric Disease and Treatment 2010, 6:1-2

Published Date: 24 August 2010